Labor in women with the new coronavirus infection (COVID-19) and HIV infection

Abstract

BACKGROUND: HIV and COVID-19 remain some of global health problems today. Complications of these diseases, pregnancy and labor, as well as the perinatal condition of newborns can make a significant contribution to the deterioration of the demographic situation in this country. Summarizing the foreign and domestic literature, one may assess the impact of each individual pathogen on the condition of the pregnant woman and the fetus. However, we have not found data on the associative or antagonistic form of symbiosis of these pathogens, as well as on the joint effect on the pregnancy, labor and the condition of newborns in the available literature.

AIM: The aim of this work was to analyze the outcomes of labor in women with the new coronavirus infection (COVID-19) and HIV infection.

MATERIALS AND METHODS: We performed a retrospective analysis of birth histories of 63 women who were delivered in S.P. Botkin Clinical Infectious Diseases Hospital (Saint Petersburg, Russia) in the period from April 2020 to March 2022. Of these, 26 birth histories are of women with a combination of HIV infection and COVID-19, and 37 birth histories of women with HIV infection alone. We assessed the severity of COVID-19 in pregnant women with HIV infection, the course of labor, complications during childbirth and the condition of newborns.

RESULTS: The groups did not differ in the duration of labor, the frequency of labor abnormalities, the volume of blood loss during delivery, the frequency of postpartum complications and the condition of newborns after one and five minutes on the Apgar scale. The duration of the anhydrous interval was significantly longer in women with HIV infection who did not suffer from COVID-19. The frequency of cesarean section was significantly higher in pregnant women with HIV infection and COVID-19. According to pathological examination, inflammatory changes in the placenta and signs characteristic of viral infection occurred more often in the group of women with HIV infection and COVID-19.

CONCLUSIONS: The presence of COVID-19 affects the course of labor in patients with HIV infection. However, the frequency of caesarean section in the group of patients with HIV infection and COVID-19 was significantly higher due to obstetric reasons, and was not related to the severity of the mother’s condition and the prenatal state of the fetus due to the infectious process. Inflammatory changes in the placenta and signs of a viral infection are more common in patients with COVID-19 and HIV infection. These data suggest that the combined course of these diseases may have a greater negative impact on the fetus than in women with HIV infection who do not suffer from COVID-19.

Keywords

pregnancy / childbirth / HIV infection / coronavirus infection / COVID-19 / newborn / complications

References

[1] World Health Organizaition [Internet]. HIV [cited 2022 Jul 28]. Available from: https://www.who.int/ru/news-room/fact-sheets/detail/hiv-aids

[2] World Health Organizaition [Электронный ресурс]. ВИЧ [дата обращения 28.01.2023]. Доступ по ссылке: https://www.who.int/ru/news-room/fact-sheets/detail/hiv-aids

[3] Federal scientific and methodological Center for the prevention and Control of AIDS [Internet]. HIV infection in the Russian Federation as of December 31, 2021 [cited 2022 Dec 14]. Available from: http://www.hivrussia.info/wp-content/uploads/2022/03/Spravka-VICH-v-Rossii-na-31.12.2021-g.pdf

[4] Федеральный научно-методический центр по профилактике и борьбе со СПИДом [Электронный ресурс]. ВИЧ-инфекция в Российской Федерации на 31 декабря 2021 г. [дата обращения 14.12.2022]. Доступ по ссылке: http://www.hivrussia.info/wp-content/uploads/2022/03/Spravka-VICH-v-Rossii-na-31.12.2021-g.pdf

[5] Federal’naya sluzhba po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiya cheloveka. O sostoyanii sanitarno-epidemiologicheskogo blagopoluchiya naseleniya v Rossiiskoi Federatsii v 2020 godu: gosudarstvennyi doklad. Moscow; 2021. (In Russ.) [cited 2023 Jan 21]. Available from: https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=18266

[6] Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека. О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2020 году: государственный доклад. Москва; 2021 [дата обращения 21.01.2023]. Доступ по ссылке: https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=18266

[7] The Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) [Internet]. COVID-19 dashboard [cited 2022 May 28]. Available from: https://www.arcgis.com/apps/dashboards/bda7594740fd40299423467b48e9ecf6

[8] The Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) [Internet]. COVID-19 Dashboard [дата обращения 28.07.2022]. Доступ по ссылке: https://www.arcgis.com/apps/dashboards/bda7594740fd40299423467b48e9ecf6

[9] Federal’naya sluzhba po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiya cheloveka. O sostoyanii sanitarno-epidemiologicheskogo blagopoluchiya naseleniya v Rossiiskoi Federatsii v 2021 godu: gosudarstvennyi doklad. Moscow; 2022. (In Russ.) [cited 2022 Jun 28]. Available from: https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=21796

[10] Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека. О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2021 году: государственный доклад. Москва, 2022 [дата обращения: 21.01.2023]. Доступ по ссылке: https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=21796

[11] Brocklehurst P, French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol. 1998;105(8):836–848. DOI: 10.1111/j.1471-0528.1998.tb10227.x

[12] Brocklehurst P., French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis // Br. J. Obstet. Gynaecol. 1998. Vol. 105. No. 8. P. 836–848. DOI: 10.1111/j.1471-0528.1998.tb10227.x

[13] Xiao PL, Zhou YB, Chen Y, et al. Association between maternal HIV infection and low birth weight and prematurity: a meta-analysis of cohort studies. BMC Pregnancy Childbirth. 2015;15:246. DOI: 10.1186/s12884-015-0684-z

[14] Xiao P.L., Zhou Y.B., Chen Y., et al. Association between maternal HIV infection and low birth weight and prematurity: a meta-analysis of cohort studies // BMC Pregnancy Childbirth. 2015. Vol. 15. P. 246. DOI: 10.1186/s12884-015-0684-z

[15] van der Merwe K, Hoffman R, Black V, et al. Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study. J Int AIDS Soc. 2011;14:42. DOI: 10.1186/1758-2652-14-42

[16] van der Merwe K., Hoffman R., Black V., et al. Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study // J. Int. AIDS Soc. 2011. Vol. 14. P. 42. DOI: 10.1186/1758-2652-14-42

[17] Kim HY, Kasonde P, Mwiya M, et al. Pregnancy loss and role of infant HIV status on perinatal mortality among HIV-infected women. BMC Pediatr. 2012;12:138. DOI: 10.1186/1471-2431-12-138

[18] Kim H.Y., Kasonde P., Mwiya M., et al. Pregnancy loss and role of infant HIV status on perinatal mortality among HIV-infected women // BMC Pediatr. 2012. Vol. 12. P. 138. DOI: 10.1186/1471-2431-12-138

[19] Cooper ER, Charurat M, Mofenson L, et al.; Women and Infants’ Transmission Study Group. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29(5):484–494. DOI: 10.1097/00126334-200204150-00009

[20] Cooper E.R., Charurat M., Mofenson L. et al.; Women and Infants’ Transmission Study Group. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission // J. Acquir. Immune. Defic. Syndr. 2002. Vol. 29. No. 5. P. 484–494. DOI: 10.1097/00126334-200204150-00009

[21] Melik-Guseynov DV, Konoplyannikov AG, Mazus AI, et al. Rekomendatsii po provedeniyu profilaktiki peredachi VICh-infektsii ot materi rebenku: metodicheskie rekomendatsii. Moscow; 2017. (In Russ.) [cited 2023 Jan 21]. Available from: https://raspm.ru/files/profilaktikaVICH.pdf

[22] Мелик-Гусейнов Д.В., Коноплянников А.Г., Мазус А.И. и др. Рекомендации по проведению профилактики передачи ВИЧ-инфекции от матери ребенку: методические рекомендации. Москва, 2017 [дата обращения: 21.01.2023]. Доступ по ссылке: https://raspm.ru/files/profilaktikaVICH.pdf

[23] de Cock KM, Fowler MG, Mercier E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA. 2000;283(9):1175–1182. DOI: 10.1001/jama.283.9.1175

[24] de Cock K.M., Fowler M.G., Mercier E., et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice // JAMA. 2000. Vol. 283. No. 9. P. 1175–1182. DOI: 10.1001/jama.283.9.1175

[25] Drake AL, Wagner A, Richardson B, et al. Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis. PLoS Med. 2014;11(2). DOI: 10.1371/journal.pmed.1001608

[26] Drake A.L., Wagner A., Richardson B., et al. Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis // PLoS Med. 2014. Vol. 11. No. 2. DOI: 10.1371/journal.pmed.1001608

[27] Naidoo M, Sartorius B, Tshimanga-Tshikala G. Maternal HIV infection and preterm delivery outcomes at an urban district hospital in KwaZulu-Natal 2011. South Afr J Infect Dis. 2016;31(1):25–28. DOI: 10.4102/sajid.v31i1.101

[28] Naidoo M., Sartorius B., Tshimanga-Tshikala G. Maternal HIV infection and preterm delivery outcomes at an urban district hospital in KwaZulu-Natal 2011 // South Afr. J. Infect. Dis. 2016. Vol. 31. No. 1. P. 25–28. DOI: 10.4102/sajid.v31i1.101

[29] Alvarez JR, Bardeguez A, Iffy L, et al. Preterm premature rupture of membranes in pregnancies complicated by human immunodeficiency virus infection: a single center’s five-year experience. J Matern Fetal Neonatal Med. 2007;20(12):853-857. DOI: 10.1080/14767050701700766

[30] Alvarez J.R., Bardeguez A., Iffy L., et al. Preterm premature rupture of membranes in pregnancies complicated by human immunodeficiency virus infection: a single center’s five-year experience // J. Matern. Fetal Neonatal. Med. 2007. Vol. 20. No. 12. P. 853–857. DOI: 10.1080/14767050701700766

[31] Bhoopat L, Khunamornpong S, Sirivatanapa P, et al. Chorioamnionitis is associated with placental transmission of human immunodeficiency virus-1 subtype E in the early gestational period. Mod Pathol. 2005;18(10):1357–1364. DOI: 10.1038/modpathol.3800418

[32] Bhoopat L., Khunamornpong S., Sirivatanapa P., et al. Chorioamnionitis is associated with placental transmission of human immunodeficiency virus-1 subtype E in the early gestational period // Mod. Pathol. 2005. Vol. 18. No. 10. P. 1357–1364. DOI: 10.1038/modpathol.3800418

[33] Temmerman M, Nyong’o AO, Bwayo J, et al. Risk factors for mother-to-child transmission of human immunodeficiency virus-1 infection. Am J Obstet Gynecol. 1995;172(2):700–705. DOI: 10.1016/0002-9378(95)90597-9

[34] Temmerman M., Nyong’o A.O., Bwayo J., et al. Risk factors for mother-to-child transmission of human immunodeficiency virus-1 infection // Am. J. Obstet. Gynecol. 1995. Vol. 172. No. 2. P. 700–705. DOI: 10.1016/0002-9378(95)90597-9

[35] Vukolova VA, En’kova EV, Ryzhikov YuS, et al. Assessment of the course of pregnancy, childbirth and the condition of the fetus in women with COVID-19. Journal of New Medical Technologies, e-edition. 2020;(6):56–62. DOI: 10.24411/2075-4094-2020-16778. (In Russ.) [cited 2020 Dec 17]. Available from: http://www.medtsu.tula.ru/VNMT/Bulletin/E2020-6/1-9.pdf

[36] Вуколова В.А., Енькова Е.В., Рыжиков Ю.С. и др. Оценка течения беременности, родов и состояния плода у женщин с COVID-19 // Вестник новых медицинских технологий. Электронное периодическое издание. 2020. № 6. С. 56–62. DOI: 10.24411/2075-4094-2020-16778 [дата обращения: 21.01.2023]. Доступ по cсылке: http://www.medtsu.tula.ru/VNMT/Bulletin/E2020-6/1-9.pdf

[37] Dashraath P, Wong JLJ, Lim MXK, et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol. 2020; 222(6):521–531. DOI: 10.1016/j.ajog.2020.03.021

[38] Dashraath P., Wong J.L.J., Lim M.X.K., et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy // Am. J. Obstet. Gynecol. 2020. Vol. 222. No. 6. P. 521–531. DOI: 10.1016/j.ajog.2020.03.021

[39] Elshafeey F, Magdi R, Hindi N, et al. A systematic scoping review of COVID-19 during pregnancy and childbirth. Int J Gynaecol Obstet. 2020;150(1):47–52. DOI: 10.1002/ijgo.13182

[40] Elshafeey F., Magdi R., Hindi N., et al. A systematic scoping review of COVID-19 during pregnancy and childbirth // Int. J. Gynaecol. Obstet. 2020. Vol. 150. No. 1. P. 47–52. DOI: 10.1002/ijgo.13182

[41] Villar J, Ariff S, Gunier RB, et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID multinational cohort study. JAMA Pediatr. 2021;175(8):817-826. DOI: 10.1001/jamapediatrics.2021.1050

[42] Villar J., Ariff S., Gunier R.B., et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID multinational cohort study // JAMA Pediatr. 2021. Vol. 75. No. 8. P. 817–826. DOI: 10.1001/jamapediatrics.2021.1050

[43] Gareyeva AI, Mozgovaya EV, Belopolskaya MA, et al. Experience in managing severe and extremely severe COVID-19 in pregnant women. Journal of Obstetrics and Women’s Diseases. 2022;71(1):11–22. (In Russ.) DOI: 10.17816/JOWD72169

[44] Гареева А.И., Мозговая Е.В., Белопольская М.А., и др. Опыт ведения беременных с тяжелой и крайне тяжелой формами COVID-19 // Журнал акушерства и женских болезней. 2022. Т. 71. № 1. C. 11–22. DOI: 10.17816/JOWD72169

[45] Schwartz DA. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med. 2020;144(7):799–805. DOI: 10.5858/arpa.2020-0901-SA

[46] Schwartz D.A. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes // Arch. Pathol. Lab. Med. 2020. Vol. 144. No. 7. P. 799–805. DOI: 10.5858/arpa.2020-0901-SA

[47] Li N, Han L, Peng M, et al. Maternal and neonatal outcomes of pregnant women with coronavirus disease 2019 (COVID-19) pneumonia: a case-control study. Clin Infect Dis. 2020;71(16):2035–2041. DOI: 10.1093/cid/ciaa352

[48] Li N., Han L., Peng M., et al. Maternal and neonatal outcomes of pregnant women with coronavirus disease 2019 (COVID-19) pneumonia: a case-control study // Clin. Infect. Dis. 2020. Vol. 71. No. 16. P. 2035–2041. DOI: 10.1093/cid/ciaa352

[49] Vashukova MA, Zinserling VA, Semenova NYu, et al. Is perinatal CoVID-19 possible: first results. Journal Infectology. 2020;12(3):51–55. (In Russ.) DOI: 10.22625/2072-6732-2020-12-3-51-55

[50] Вашукова М.А., Цинзерлинг В.А., Семенова Н.Ю., и др. Возможна ли перинатальная COVID-19: первые результаты // Журнал инфектологии. 2020. Т. 12. № 3. С. 51–55. DOI: 10.22625/2072-6732-2020-12-3-51-55

[51] Wu Y, Liu C, Dong L, et al. Coronavirus disease 2019 among pregnant Chinese women: case series data on the safety of vaginal birth and breastfeeding. BJOG. 2020;127(9):1109–1115. DOI: 10.1111/1471-0528.16276

[52] Wu Y., Liu C., Dong L., et al. Coronavirus disease 2019 among pregnant Chinese women: case series data on the safety of vaginal birth and breastfeeding // BJOG. 2020. Vol. 127. No. 9. P. 1109–1115. DOI: 10.1111/1471-0528.16276

[53] Belopolskaya MA, Gareeva AI, Avrutin VYu, et al. Risk of COVID-19 in newborns depending on the infection course in the mother. Journal Infectology. 2022;14(1):105–110. (In Russ.) DOI: 10.22625/2072-6732-2022-14-1-105-110

[54] Белопольская М.А., Гареева А.И., Аврутин В.Ю., и др. Анализ риска инфицирования новорожденных в зависимости от течения COVID-19 у матери // Журнал инфектологии. 2022. Т. 14. № 1. С. 105–110. DOI: 10.22625/2072-6732-2022-14-1-105-110

[55] Khan S, Jun L, Nawsherwan, et al. Association of COVID-19 with pregnancy outcomes in health-care workers and general women. Clin Microbiol Infect. 2020;26(6):788–790. DOI: 10.1016/j.cmi.2020.03.034

[56] Khan S., Jun L., Nawsherwan, et al. Association of COVID-19 with pregnancy outcomes in health-care workers and general women // Clin. Microbiol. Infect. 2020. Vol. 26. No. 6. P. 788–790. DOI: 10.1016/j.cmi.2020.03.034

[57] Pierce-Williams RAM, Burd J, Felder L, et al. Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study. Am J Obstet Gynecol MFM. 2020;2(3). DOI: 10.1016/j.ajogmf.2020.100134

[58] Pierce-Williams R.A.M., Burd J., Felder L., et al. Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study // Am. J. Obstet. Gynecol. MFM. 2020. Vol. 2. No. 3. DOI: 10.1016/j.ajogmf.2020.100134

[59] Guan WJ, Ni ZY, Hu Y, et al.; China medical treatment expert group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. DOI: 10.1056/NEJMoa2002032

[60] Guan W.J., Ni Z.Y., Hu Y., et al.; China medical treatment expert group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China // N. Engl. J. Med. 2020. Vol. 382. No. 18. P. 1708–1720. DOI: 10.1056/NEJMoa2002032

RIGHTS & PERMISSIONS

Gareyeva A.I., Kovalchuk A.S., Lioznov D.A., Sudakov D.S., Nesvit E.M., Kucheryavenko A.N.